Sign up to save your podcasts
Or
Share A September Skip, The Bullish Case for Viking Therapeutics, and Lassoing the Laggards 8/19/25
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A September Skip, The Bullish Case for Viking Therapeutics, and Lassoing the Laggards 8/19/25
Why the Fed could skip a September cut altogether, despite higher inflation data. BTIG makes the case for sticking with Viking Therapeutics despite disappointing weight loss drug trial data. Plus, the laggards our traders says to buy now.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
View all episodes
By CNBC
3.9
306306 ratings
Why the Fed could skip a September cut altogether, despite higher inflation data. BTIG makes the case for sticking with Viking Therapeutics despite disappointing weight loss drug trial data. Plus, the laggards our traders says to buy now.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
More shows like The Exchange
View all
Mad Money w/ Jim Cramer
4,096 Listeners
CNBC's "Fast Money"
1,357 Listeners
CNBC's "Options Action"
240 Listeners
Your Money Minute
147 Listeners
Exchanges
971 Listeners
Fortt Knox
67 Listeners
Strange Success with Jane Wells
154 Listeners
American Greed Podcast
2,159 Listeners
Thoughts on the Market
1,289 Listeners
Squawk on the Street
591 Listeners
Squawk Pod
562 Listeners
The Keynote by CNBC Events
20 Listeners
Barron's Live
195 Listeners
Halftime Report
420 Listeners
CNBC's "Last Call"
301 Listeners
Worldwide Exchange
121 Listeners
RiskReversal Pod
809 Listeners
MRKT Matrix
180 Listeners
TechCheck
61 Listeners
Closing Bell
151 Listeners
Manifest Space with Morgan Brennan
34 Listeners
CNBC’s “Money Movers”
14 Listeners
Power Lunch
22 Listeners
The Crimes of Putin’s Trader
277 Listeners
CNBC Business News Update
10 Listeners
CNBC Sport
16 Listeners